SUMMARY Bone marrow infiltrates taken from 11 patients with peripheral T cell lymphoma were immunophenotyped as T cell lymphoma using monoclonal antibodies on frozen bone marrow trephine biopsy specimens. In nine these were taken at diagnosis and in two after failure of treatment to eradicate lymphoma in the marrow. Patterns of infiltration were as follows: diffuse (n = 4), interstitial (n = 1), nodular (n = 1), focal (n = 5). All cases were CD3 positive and 10 were CD2 positive; five lacked expression ofeither CD5 or CD7, or both markers. In nine the determination ofT cell phenotype depended on analysis of the frozen bone marrow trephine biopsy specimen as there was no other biopsy tissue available for study. In the other two cases there was agreement between the immunophenotypes seen in lymph node and bone marrow infiltrates.
Peripheral T cell lymphoma comprises a group of malignancies with diverse histology, often with an admixture of cell types.'4 Presentation is often with extranodal disease,2-5 and the interpretation of extranodal tissue is often more complex than that of lymph node biopsy specimens in lymphoma. Further diagnostic difficulties arise as extranodal biopsy specimens are frequently fixed in formalin and so are not usually suitable for immunohistological analysis using panels of T cell antibodies reactive with frozen sections or cells in suspension. Investigation of frozen tissue using monoclonal antibodies often shows heterogeneous phenotypes346 with the neoplastic cells lacking one or more of the pan T cell antigens.57
In several studies bone marrow infiltration has been a common finding in peripheral T cell lymphoma.89 Bone marrow morphology usually resembles that seen in other infiltrated tissues,9 in contrast to B cell lymphomas where the histological appearance of the lymphoma in the marrow is frequently different from that seen elsewhere.'" T cell lymphoma in the marrow may be associated with red cell aplasia" 2 or the myelodysplastic syndrome,'3 14 and the histological appearances of the marrow in such cases can be confusing. For example, Auger et al described three cases of T cell lymphoma, one with the marrow appearances of refractory anaemia with an excess of myeloblasts, and two with hypercellular marrow treAccepted for publication 16 November 1988 phine biopsy specimens which contained increased numbers of either atypical megakaryocytes or megakaryoblasts, a "left shifted" myeloid series, and either "left shifted" or dysplastic erythroid cell lines, suggestive of a myeloproliferative disorder.'3 In all three cases the characteristic pattern of marrow infiltration by mature post-thymic T cells became evident at a later stage in the disease.
Primary presentation with bone marrow infiltration may occur in T cell lymphoma in the absence ofdisease elsewhere.83 Usually, a bone marrow biopsy specimen from a patient with asymptomatic peripheral blood cytopenia is the first evidence of disease. In this study seven of 11 patients presented with peripheral blood cytopenias, lymphomatous infiltration of the marrow, and an absence of disease at other sites that could be biopsied. Immunophenotypic analysis of frozen marrow trephine material was essential to diagnose T cell lymphoma. The remaining four patients presented with lymphadenopathy and node biopsy specimens confirmed a diagnosis of non-Hodgkin's lymphoma. specimens. Details of these 11 cases are outlined in described previously.'5 Marrow trephine biopsy specimens were taken Marrow was aspirated from the posterior iliac crest using an 8 G Islam needle after removal of aspirate and smears were prepared routinely for staining with from the posterior iliac crest and the biopsy specimen May-Grunwald-Giemsa. In addition, 1-2 ml of was immediately divided in half using a razor blade. aspirate were taken into medium containing heparin The outer half containing any cortical bone was put for preparation of mononuclear cell suspensions, as into formalin for conventional processing and staining Bone marrow immunophenotyping in peripheral T cell lymphoma with haematoxylin and eosin, Giemsa, periodic acid Schiff and reticulin. The inner half was immersed in Histocon (Polysciences) kept at 4°C for four to 12 hours and stored frozen at -70°C before sectioning. Inside the cryostat (cabinet temperature -35°C) the frozen trephine biopsy specimen was mounted in OCT compound and orientated so that the long axis was perpendicular to the knife edge. Sections (5 pm) were picked up on slides coated with 0-01% poly-L-lysine. The disposable blades were adjusted frequently to give a fresh cutting edge. Sections were left at room temperature overnight, fixed for 10 minutes in dry acetone, and after air drying for 10 minutes the slides were immersed in Tris buffered saline (TBS), pH 7-6, in preparation for staining using the alkaline phosphatase anti-alkaline phosphatase (APAAP) method described by Cordell et al. '6 The method entailed incubation with the primary monoclonal antibody, followed by goat anti-mouse Ig (GAM) and monoclonal APAAP complexes. Each incubation step lasted 30 minutes and was followed by washing in TBS. By repeating incubations with GAM and APAAP complexes (for 10 11 patients had been treated for rheumatoid arthritis. All 11 patients had lymphomatous infiltration of marrow seen on the bone marrow trephine biopsy specimen at diagnosis.
Five patients presented with pancytopenia, four others had a less pronounced peripheral blood Nolymphnodebiopsy ND= Not done tFrozen trephine biopsy specimen taken after treatment. 405 406 cytopenia. Five patients presented with peripheral lymphadenopathy, three others had retroperitoneal lymphadenopathy seen on ultrasound or computed tomography scan, and the remaining three had splenomegaly without lymphadenopathy. Of the nine patients tested for serum immunoglobulins, six had decreased IgG and four of them also had low IgA and IgM. No patient had hypergammaglobulinaemia. In four of 10 patients dyserythropoiesis was seen in the marrow aspirate, two had a pronounced lack of erythroid activity, and one patient (direct Coomb's test positive) had erythroid hyperplasia. Ten patients received varying forms ofcombination chemotherapy. Of these, one patient failed to respond and nine had only a partial response.
Seven patients died, all of them of lymphoma. The median survival was six months and four patients were alive in partial remission at 13, 18, 20 and 40 months. In none of these four patients has lymphoma been eradicated from the marrow.
Immunophenotypic analysis of infiltrates in frozen bone marrow trephine biopsy specimens (table 2) showed that all cases were positive for CD3 and nine of 11 were positive for CD2. Only one was positive for CDI, a marker of immature T cells. Four cases had lost positivity for CD7, and two were also negative for CD5. Eight of nine cases were positive for CD4 and there were no cases positive for CD8.
Seven of 1 were HLA class II positive and three were positive for WR16, a CD45 restricted monoclonal antibodies which marks a subset of CD4 positive cells that act as functional supressors.'7 Staining using UCHLI'8 was weak and diffuse and therefore regarded as artefactual. Four of nine were positive for CD25, a marker for the IL-2 receptor. Only three of 11 were positive for CD38 (T10), an activation marker. There was variable positivity for Ki-67, a monoclonal antibody that is a marker of proliferation.'9 ranging from 0-62%. The percentage positivity with the Ki-67 index was calculated by counting 100 cells in each of the three most heavily positive areas in the infiltrate, as these areas tended to occur as isolated nodules of proliferation within an infiltrated area. All T cell lymphomas with a Ki-67 index of > 10% were positive for OKT9, a marker for the transferrin receptor.
In only two cases was frozen lymph node biopsy material available for immunophenotyping, and in these cases lymph node and marrow immunophenotypes were the same.
Discussion
All 11 cases of peripheral T cell lymphoma investigated in this study had lymphomatous infiltration seen in conventionally processed marrow trephine White, Smith, Whitehouse, Smith biopsy specimens. Previous studies have reported a variable incidence of bone marrow disease in peripheral T cell lymphoma89-up to 80% in some studies of bilateral marrow trephine biopsy specimens.8 One study by Foucar et al of a series of 176 cases of non-Hodgkin's lymphoma showed that 51% of B cell lymphomas and 65% of T cell lymphomas had marrow infiltration.'" As observed in previous studies we found an absence of paratrabecular infiltrates in these cases of peripheral T cell lymphoma.9 Due to the high incidence of bone marrow infiltration in peripheral T cell lymphoma reported in some studies the immunological analysis of frozen bone marrow trephine biopsy specimens is potentially a very useful technique. This was the case in this group of 11 cases where only five patients presented with peripheral lymphadenopathy (in one case lymphadenopathy developed after analysis of the frozen bone marrow trephine biopsy specimen had already established the diagnosis). In only two of five lymph node biopsy specimens was fresh tissue taken for analysis. A particular problem in diagnosis arose in the two cases presenting with central nervous system disease. Examination ofcerebrospinal fluid was not diagnostic and brain biopsy was contraindicated due to thrombocytopenia. In both these cases investigation of the frozen bone marrow trephine biopsy specimen led to the diagnosis of peripheral T cell lymphoma. Such cases may previously have gone undiagnosed as peripheral T cell lymphoma because the diagnosis often relies on the pattern ofinfiltration oflymph node plus immunophenotype (for example, T zone lymphoma). The appearances of peripheral T cell lymphoma in the marrow are not pathognomonic8 and not so easily recognisable as those seen in the lymph node. We also found that the immunological analyses of bone marrow aspirates are usually non-diagnostic.
Cases of non-Hodgkin's lymphoma have previously been investigated using frozen marrow trephine biopsy specimens. In Most cases (seven of I 1) were positive for HLA class II, which is a marker of activation seen in T cell lymphoma22 26; resting T cells are HLA class II negative. Two cases had lost the pan T cell marker CD2 but none had lost CD3, confirming the usefulness of CD3 in the diagnosis of T cell lymphoma. Other studies have reported the loss of most pan T cell antigens in some cases of peripheral T cell lymphoma, especially when the lymphoma consists of larger neoplastic cells,23 thus leading to problems in the differential diagnosis between peripheral T cell lymphoma, diffuse aggressive B-non-Hodgkin's lymphoma, and Hodgkin's disease. In our series four of 11 cases had lost the pan T cell marker CD7 and two of 10 CD5. A total of five of 11 cases had lost at least one pan T cell marker.
Three of our 11 patients showed dyserythropoietic changes in marrow aspirates taken at diagnosis: one of these manifested red cell hypoplasia which resolved following chemotherapy. Red cell aplasia is thought to be secondary to lymphocyte inhibition of erythropoiesis,12 perhaps by IL-1 inhibiting the action of erythropoietin on erythoid precursors." In theory this inhibition could be mediated by a malignant proliferation of T cells. T cell lymphoma has been reported to be associated with both red cell aplasia" 12 and the myelodysplastic syndromes'3 14 but the exact relation is unclear.
The analysis of marrow aspirate in our cases proved unhelpful in diagnosis due to the large numbers of T cells present in normal marrow. For immunological analysis of marrow to be useful when lymphomatous infiltration by T cells occurs, the architecture must be preserved.
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